I2-imidazoline receptors in platelets of patients with Parkinson's disease and Alzheimer's type dementia

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 199-202

  Ulibarri, Isabel ^a   Soto, Johanka ^a   Ruiz, Javier ^a   Ballesteros, Javier ^a,b   Jaúregui, José V ^b   Meana, J Javier ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Psychiatric Hospital Aita Menni   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBIDOPA; EFAROXAN; GUANABENZ; IDAZOXAN; IMIDAZOLINE I2 RECEPTOR; LEVODOPA; SELEGILINE; ANTIPARKINSON AGENT; DRUG RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTORS;

AGED; ALZHEIMER DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; IMMUNOREACTIVITY; LIGAND BINDING; MAJOR CLINICAL STUDY; MITOCHONDRIAL MEMBRANE; PARKINSON DISEASE; PROTEIN DOMAIN; THROMBOCYTE MEMBRANE; ARTICLE; BLOOD; CELL MEMBRANE; KINETICS; METABOLISM; REFERENCE VALUE; THROMBOCYTE;

ALZHEIMER DISEASE; ANTIPARKINSON AGENTS; BLOOD PLATELETS; CELL MEMBRANE; HUMANS; IDAZOXAN; IMIDAZOLES; KINETICS; PARKINSON DISEASE; RECEPTORS, DRUG; REFERENCE VALUES; SELEGILINE;

EID: 0032588761     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09360.x     Document Type: Conference Paper

References (15)

1. 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol. Pharmacol. 35: 324-330.
2. Piletz, J. E. & K. Sletten. 1993. Nonadrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267: 1493-1502.
3. 2 sites. J. Pharmacol. Exp. Ther. 272: 681-688.
4. Raddatz, R., A. Parini & S. M. Lanier. 1995. Imidazoline/guanidinium binding domains on monoamine oxidases: Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. J. Biol. Chem. 270: 27961-27968.
5. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270: 9856-9861.
6. Raddatz, R., A. Parini & S. M. Lanier. 1997. Localization of the imidazoline binding domain on monoamine oxidase B. Mol. Pharmacol. 52: 549-553.
7. 2-imidazoline receptors in rat liver. Br. J. Pharmacol. 121: 901-912.
8. Chen, K., H.-F. Wu & J. C. Shih. 1993. The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical. J. Neurochem. 61: 187-190.
9. Danielczyk, W., M. Streifler, C. Konradi, P. Riederer & G. Moll. 1988. Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infaret dementia. Acta Psychiatr. Scand. 78: 730-736.
10. Bongioanni, P., M. Donato, M. Castagna & F. Gemignani. 1996. Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients. J. Neural Transm. 103: 491-501.
11. Parnetti, L., G. P. Reboldi, C. Santucci, A. Santucci, A. Gaiti, M. Brunetti, C. Cecchetti & U. Senin. 1994. Platelet MAO-B activity as a marker of behavioural characteristics in dementia disorders. Aging Clin. Exp. Res. 6: 201-207.
12. 2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease. Neurosci. Lett. 160: 109-112.
13. Reynolds, G. P., R. M. Boulton, S. J. Pearson, A. L. Hudson & D. J. Nutt. 1996. Imidazoline binding sites in Huntington's and Parkinson's disease putamen. Eur. J. Pharmacol. 301: R19-R21.
14. 2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease. Neurochem. Int. 30: 31-36.
15. García-Sevilla, J. A., P. V. Escribá, M. Sastre, C. Walzer, X. Busquets, G. Jaquet, D. J. Reis & J. Guimón. 1996. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch. Gen. Psychiatry 53: 803-810.